Publications by authors named "Hugh Zhao"

Claim this Profile
A
A novel paclitaxel eluting bioresorbable vascular stent with a super flexible stent structure and round cross section struts fabricated using 3D printing technology with a rotating platform.
Wei Liu, Qingqing Li, Ge Song, Zhiqi Lin, Xiaofei Gong, Hugh Q Zhao

Regen Biomater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of three-dimensionally printed vascular stents of bioresorbable poly(l-lactide-co-caprolactone).
Justin Zhao, Ge Song, Qinghua Zhao, Hanqing Feng, Yunbing Wang, Hugh Zhao

J Biomed Mater Res B Appl Biomater· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review on biodegradable biliary stents: materials and future trends.
Ge Song, Hugh Q Zhao, Qing Liu, Zhongyong Fan

Bioact Mater· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries.
Alexander Nikanorov, Martin Schillinger, Hugh Zhao, Erich Minar, Lewis B Schwartz

EuroIntervention· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy.
Vijaya B Kolachalama, Stephen D Pacetti, Joseph W Franses, John J Stankus, Hugh Q Zhao

Circulation· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.
Hugh Q Zhao, Alexander Nikanorov, Renu Virmani, Lewis B Schwartz

J Vasc Surg· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity.
Joyce James, Bruce Ruggeri, Robert C Armstrong, Martin W Rowbottom, Susan Jones-Bolin, Hugh Zhao

Mol Cancer Ther· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating.
Hugh Q Zhao, Dudley Jayasinghe, Syed Hossainy, Lewis B Schwartz

J Biomed Mater Res A· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): a novel oncology therapeutic agent.
Robert L Hudkins, Nadine C Becknell, Allison L Zulli, Ted L Underiner, Thelma S Angeles, Hugh Zhao

J Med Chem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic Swine.
Juan F Granada, Krzysztof Milewski, Hugh Zhao, John J Stankus, Armando Tellez

Circ Cardiovasc Interv· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late stent expansion and neointimal proliferation of oversized Nitinol stents in peripheral arteries.
Hugh Q Zhao, Alexander Nikanorov, Renu Virmani, Russell Jones, Erica Pacheco

Cardiovasc Intervent Radiol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
Roberto Piva, Bruce Ruggeri, Michael Williams, Giulia Costa, Ilaria Tamagno, Hugh Zhao

Blood· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmural communication at a subcellular level may play a critical role in the fallout based-endothelialization of dacron vascular prostheses in canine.
Ze Zhang, Stephen Briana, Yvan Douville, Hugh Zhao, Nathalie Gilbert

J Biomed Mater Res A· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice.
Susan Jones-Bolin, Hugh Zhao, Kathryn Hunter, Andres Klein-Szanto, Bruce Ruggeri

Mol Cancer Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist.
Pawel Dobrzanski, Kathryn Hunter, Susan Jones-Bolin, Hong Chang, Candy Robinson, Hugh Zhao

Cancer Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.
Sheila J Miknyoczki, Susan Jones-Bolin, Sonya Pritchard, Kathryn Hunter, Hugh Zhao

Mol Cancer Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis